Enanta Pharmaceuticals, Inc. Reports Financial Results for the Third Fiscal Quarter and Nine Months Ended June 30, 2013
8/12/2013 6:51:29 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today reported financial results for its third fiscal quarter and nine months ended June 30, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by